Cue Biopharma Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Cue Biopharma is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on therapies for autoimmune and inflammatory diseases. It is developing a novel class of therapeutic biologics that selectively engage and modulate disease-relevant T cells, aiming to harness the body's innate immune potential. The company relies on its Immuno-STAT platform to alter T cells in a disease-specific manner while avoiding broad systemic immune activation. With a footprint described as small to mid-sized in the biotechnology sector, Cue Biopharma concentrates on targeted immunotherapies rather than broad-acting approaches.
In April 2026, Cue Biopharma announced the appointment of Shao-Lee Lin as chief executive officer, president and director. This leadership change reflects a recent governance update for the clinical-stage company.

Get verified Cue Biopharma emails free

Company overview Employee directory